This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Circulation: CardiovascularImaging, Ahead of Print. In addition to the traditional clinical risk factors, an increasing amount of imagingbiomarkers have shown value for cardiovascular risk prediction.
Studies examining cardiovascular outcomes or symptoms following an episode of sepsis in adults were included. Results We identified 11 210 articles of which 70 were eligible for full text review and 28 were included in final analysis.
Her research focuses on women’s cardiovascular health and cardio-obstetrics, cardiovascular risk prediction using coronary artery calcium scores and biomarkers, lipids, and cardiometabolic diseases. Morris leads its Seinsheimer Cardiovascular Health Program and is co-director of MUSC Women’s Heart Care.
A new state-of-the-art review published March 5 in JACC: CardiovascularImaging summarizes a discussion by the Amyloidosis Forum on the role of imagingbiomarkers as trial endpoints in the diagnosis and assessment of systemic immunoglobin light chain (AL) and transthyretin (ATTR) amyloidosis.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content